HE WEI-WU purchased 7.8% of their position (400K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $394.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/19/2021ACC: 0001104659-21-141867
Director10% Owner
Since Dec 2018
+400K
Net shares
Net buyer
$394.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
400K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+200K
Price / share
$0.99
Trade value
$198K
% of position
3.9%
11/17/2021
5.16M→5.36M
Common Stock
Direct
Shares
+200K
Price / share
$0.98
Trade value
$196K
% of position
3.7%
11/18/2021
5.36M→5.56M
Total
Net shares
+400K
Net value
$394K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2021 | P · Purchase | +200K | $0.99 | $198K | 3.9% | 5.16M | 5.36M |
| Common Stock Direct | 11/18/2021 | P · Purchase | +200K | $0.98 | $196K | 3.7% | 5.36M | 5.56M |
| Total | +400K | $394K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned7.53M
Common Stock
IndirectShares owned441.07K
Common Stock
IndirectShares owned3M
Total
10.97M indirect10.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.53M | Indirect |
| Common Stock | 441.07K | Indirect |
| Common Stock | 3M | Indirect |
| Total | 10.97M | 10.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported